Fulcrum Therapeutics Inc (FULC)
3.09
-0.23
(-6.93%)
USD |
NASDAQ |
Nov 15, 10:26
Fulcrum Therapeutics Cash and Short Term Investments (Quarterly): 273.78M for June 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 273.78M |
March 31, 2024 | 213.31M |
December 31, 2023 | 236.22M |
September 30, 2023 | 257.09M |
June 30, 2023 | 278.16M |
March 31, 2023 | 297.84M |
December 31, 2022 | 202.92M |
September 30, 2022 | 221.79M |
June 30, 2022 | 168.97M |
March 31, 2022 | 195.11M |
December 31, 2021 | 218.16M |
September 30, 2021 | 240.34M |
Date | Value |
---|---|
June 30, 2021 | 125.55M |
March 31, 2021 | 143.86M |
December 31, 2020 | 112.91M |
September 30, 2020 | 127.02M |
June 30, 2020 | 131.74M |
March 31, 2020 | 81.21M |
December 31, 2019 | 96.71M |
September 30, 2019 | 101.60M |
June 30, 2019 | 49.63M |
March 31, 2019 | 62.45M |
December 31, 2018 | 72.80M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
81.21M
Minimum
Mar 2020
297.84M
Maximum
Mar 2023
190.67M
Average
202.92M
Median
Dec 2022
Cash and Short Term Investments (Quarterly) Benchmarks
Bioventus Inc | 43.07M |
Arcturus Therapeutics Holdings Inc | 237.18M |
Johnson & Johnson | 20.30B |
Entrada Therapeutics Inc | 449.34M |
Tenon Medical Inc | 1.968M |